Furthermore, inhibiting VEGFR2 with pharmacological kinase inhibitors or gene silencing reversed alterations in epithelial-mesenchymal transition-related genes and decreased the activation of fibrotic factors mediated by Gremlin, delaying the onset of renal fibrosis.[48]. The gene discussed is GREM1; the disease is renal fibrosis.